Re: 50/50 at best on Zen being sold this year IMO..

...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Reply New Message

Prev Message Back To Forum Threaded View Next Message

Telepanel

Rank: Treasurer [?]

Points: 1140 [?]

Votes: 22 Score: 2.2 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: 50/50 at best on Zen being sold this year IMO..

in response to

Re: 50/50 at best on Zen being sold this year IMO..

dutchfella

posted on May 14, 2020 12:30PM

You say they could not sell that 2million US offering at 2$when did they try? I don't remember a failed offering for Zenith.Please update me.

1 Recommendations

Reply New Message

Prev Message Back To Forum Threaded View Next Message

Please to post a reply